**Exhibit
      31.2 - CERTIFICATION**  **PURSUANT
      TO SARBANES-OXLEY SECTION 302**





I,
      John
      D. Stanton, certify that:





1. I
      have
      reviewed this annual report on Form 10-KSB of Nanobac Pharmaceuticals,
      Incorporated;





2. Based
      on
      my knowledge, this annual report does not contain any untrue statement of a
      material fact or omit to state a material fact necessary to make the statements
      made, in light of the circumstances under which such statements were made,
      not
      misleading with respect to the period covered by this annual
      report;





3. Based
      on
      my knowledge, the financial statements, and other financial information included
      in this annual report, fairly present in all material respects the financial
      condition, results of operations and cash flows of the Registrant as of, and
      for, the periods presented in this annual report;





4. I
      am
      responsible for establishing and maintaining disclosure controls and procedures
      (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the Registrant
      and have:





|(a) | Designed
              such disclosure controls and procedures or caused such disclosure controls
              and procedures to be designed under my supervision, to ensure that
              material information relating to the Registrant including its consolidated
              subsidiaries, is made known to us by others within these entities,
              particularly during the period in which this report is being
              prepared;
|--- | ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------




|(b) | Evaluated
              the effectiveness of the Registrant’s disclosure controls and procedures
              and presented in this report our conclusions about the effectiveness
              of
              the disclosure controls and procedures, as of the end of the period
              covered by this report based on such evaluation; and
|--- | ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------




|(c) | Disclosed
              in this report any change in the Registrant’s internal control over
              financial reporting that occurred during the Registrant’s most recent
              fiscal quarter (the Registrant’s fourth fiscal quarter in the case of an
              annual report) that has materially affected, or is reasonably likely
              to
              materially affect, the Registrant’s internal control over financial
              reporting; and
|--- | -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------




5. I
      have
      disclosed, based on our most recent evaluation of internal control over
      financial reporting, to the Registrant’s auditors and the audit committee of the
      Registrant’s board of directors (or persons performing the equivalent
      functions);





|(a) | All
              significant deficiencies in the design or operation of internal controls
              over financial reporting which are reasonably likely to adversely affect
              the Registrant’s ability to record, process, summarize and report
              financial data information; and
|--- | ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------




|(b) | Any
              fraud, whether or not material, that involves management or other
              employees who have a significant role in the Registrant’s internal
              controls over financial reporting.
|--- | ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------




Date: May 1, 2007
              /s/ John D. StantonJohn D. Stanton
                Chief Financial
                  Officer